Clinical Trial Update: Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution [EARLY_Phase 1]

View source ↗

Summary

This early-phase (Phase 1) trial characterized the wound microbiome in dystrophic and junctional Epidermolysis Bullosa and examined changes after applying APR-T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• APR-TD011 Spray Solution

Snippet

Sponsor: Northwestern University | Conditions: Epidermolysis Bullosa | EARLY_Phase 1 | Status: COMPLETED